What is an integrated intake workflow algorithm for patients entering a medication-assisted treatment (MAT) opioid treatment program (OTP) that includes medical, dental, and behavioral health services?

Integrated MAT OTP Intake Workflow Algorithm

Implement a same-day, low-barrier intake process that simultaneously initiates medication-assisted treatment while conducting parallel assessments across medical, dental, and behavioral health domains to maximize treatment retention and reduce mortality from opioid use disorder. 1, 2, 3

Initial Contact & Same-Day Access (Day 1)

Immediate Triage & Stabilization

• Screen for withdrawal symptoms using Clinical Opiate Withdrawal Scale (COWS)
• Assess overdose risk: recent fentanyl use, polysubstance use, unstable housing
• Distribute naloxone and safer use supplies (fentanyl test strips, wound care) immediately 4
• Do not delay MAT initiation for completion of comprehensive assessments 5, 6

Medication Initiation Protocol

• Methadone: Begin dosing same day if patient meets federal OTP criteria (age ≥18 years for most programs; ≥16 years with documented exceptions) 1, 3
• Buprenorphine: Initiate if patient in moderate withdrawal (COWS ≥8-12) and prefers office-based treatment 1
• Naltrexone: Consider only after complete detoxification (7-10 days opioid-free); useful for patients with co-occurring alcohol use disorder or unstable housing 1

Critical Pitfall

Federal regulations restrict methadone to patients ≥18 years in most OTPs, though buprenorphine is FDA-approved for ages ≥16 years 1. Do not turn away adolescents—refer immediately to programs with adolescent waivers or initiate buprenorphine.

Parallel Integrated Assessment (Days 1-7)

Medical Assessment Components

Conduct within first week, not as barrier to treatment entry:

• Infectious disease screening: HIV, hepatitis C, hepatitis B surface antigen 1, 7
• Cardiovascular risk: Blood pressure (25-46% of OTP patients have hypertension risk), baseline ECG for methadone QTc monitoring 7
• Metabolic screening: Fasting glucose, lipid panel (obesity present in majority of OTP patients) 7
• Tobacco use assessment: 60% are heavy smokers—integrate smoking cessation 7
• Injection-related complications: Examine for endocarditis, abscesses, cellulitis 1

Behavioral Health Assessment

85% of OTP patients have multiple mental health risks 7:

• Screen for: Depression (PHQ-9), anxiety (GAD-7), PTSD (PCL-5)
• Assess functional status: Capability of managing healthcare needs, housing stability
• Identify co-occurring substance use: Alcohol, benzodiazepines, stimulants
• Assign behavioral health clinician for integrated counseling (required for optimal outcomes) 1, 2

Dental Assessment

Schedule within 30 days:

• Screen for dental pain, abscesses, caries (common in chronic opioid use)
• Coordinate with on-site or affiliated dental services
• Address barriers: transportation, cost, stigma

Integrated Care Team Structure

Staffing Matrix 2, 3

• Physician/NP/PA: MAT prescribing, medical management, treatment plans
• Behavioral health clinician: Individual/group counseling, trauma-informed care
• Care coordinator: Appointment scheduling, social determinants of health navigation
• Peer recovery specialist: Lived experience support, retention engagement
• Nursing staff: Medication dispensing (methadone), vital signs, UTOX collection
• Dental provider: Co-located or referral partnership

Workflow Integration Strategy

Critical implementation lesson from research 2: New services add to already busy workflows. Address this by:

• Co-locate services in same physical space to reduce patient burden 3
• Use shared electronic health record with real-time dashboards for appointment attendance, urine toxicology results 8
• Conduct weekly interdisciplinary team meetings for care coordination 2
• Implement quality improvement processes with change champions to adapt workflows 2

Ongoing Monitoring & Retention (Weeks 2-12)

Medication Management

• Methadone: Titrate to therapeutic dose (typically 60-120mg), monitor for QTc prolongation
• Buprenorphine: Adjust to suppress cravings/withdrawal (typically 12-24mg daily)
• Urine toxicology: Regular monitoring (not punitive)—33% engagement improves with mHealth support 8

Retention Benchmarks

• 90-day retention: Target ≥60-70% (achievable with integrated model) 3
• 180-day retention: Maintain similar rates through peer support and care coordination 3
• Address gaps >35 days: Immediate outreach by care coordinator or peer specialist 8

Addressing Social Determinants

73% of patients report pandemic-related impacts 5:

• Screen for housing instability, food insecurity, transportation barriers
• Connect to community resources, case management
• Offer telemedicine/telebehavioral health options (86% find effective) 5

Key Implementation Facilitators

Based on multi-site implementation research 2, 6:

• External facilitation: Partner with academic institutions or technical assistance providers
• Simplified QI processes: Regular post-implementation meetings, data-driven adaptations
• Staff training: Ongoing education on harm reduction philosophy, integrated care workflows
• Regulatory navigation: OTP manages DEA/state compliance; FQHC manages primary care billing 3

Common Pitfall

Staff may resist philosophical shift from abstinence-only to harm reduction. Address through continuous training, change champions, and demonstrating improved patient outcomes 2, 6.

Critical Success Factors

The OTP setting provides strong foundation for integrated care 2, 7, but success requires:

1. Low-threshold entry: Minimize barriers, same-day MAT initiation 5, 6
2. Adequate staffing: Do not underestimate workflow burden of comprehensive services 2
3. Coordinated treatment teams: Shared goals, regular communication, unified EHR 3, 8
4. Harm reduction approach: Naloxone distribution, safer use supplies, non-punitive monitoring 4
5. Address 60% with multiple mental health risks and 85% with multiple physical health risks simultaneously 7

This integrated model improves general functioning, reduces mental health symptoms, and decreases heavy smoking while maintaining high retention rates 2, 7.